MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

05 May 2022 Evaluate
The revenue for the March 2022 quarter is pegged at Rs. 2678.20 millions, about 22.21% up against Rs. 2191.50 millions recorded during the year-ago period.Net Profit witnessed a 224.41% growth almost the double from Rs. 157.70 millions to Rs. 511.60  millions  of same quarter last year.Operating profit for the quarter ended March 2022 rose to 711.20 millions as compared to 339.70 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202106 202006 % Var
Sales 2678.20 2191.50 22.21 8185.20 7233.40 13.16 10087.30 8911.96 13.19
Other Income 23.50 32.40 -27.47 100.90 156.80 -35.65 181.00 337.27 -46.33
PBIDT 711.20 339.70 109.36 2187.70 2132.60 2.58 2641.20 2444.80 8.03
Interest 1.40 2.00 -30.00 4.00 6.30 -36.51 8.00 0.00 0.00
PBDT 709.80 337.70 110.19 2183.70 2126.30 2.70 2633.20 2444.80 7.71
Depreciation 61.20 76.70 -20.21 196.10 228.80 -14.29 300.40 206.18 45.70
PBT 648.60 261.00 148.51 1987.60 1897.50 4.75 2332.80 2238.62 4.21
TAX 137.00 103.30 32.62 473.90 468.40 1.17 564.80 545.70 3.50
Deferred Tax -5.90 2.80 -310.71 -10.90 -11.30 -3.54 -49.00 94.90 -151.63
PAT 511.60 157.70 224.41 1513.70 1429.10 5.92 1768.00 1692.92 4.43
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 26.56 15.50 71.32 26.73 29.48 -9.35 26.18 27.43 -4.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..